1
|
Chowdhury FM, Ahsan CR, Birkeland NK. Oral immunization of Escherichia albertii strain DM104 induces protective immunity against Shigella dysenteriae type 4 in mouse model. Acta Microbiol Immunol Hung 2021. [PMID: 34292874 DOI: 10.1556/030.2021.01431] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2021] [Accepted: 07/05/2021] [Indexed: 11/19/2022]
Abstract
The recent rise of antibiotic resistance and lack of an effective vaccine make the scenario of shigellosis alarming in developing countries like Bangladesh. In recent years, our group reported the vaccine efficacy of a non-pathogenic Escherichia albertii strain DM104 in different animal models, where an ocularly administered vaccine in the guinea pig eye model against Shigella dysenteriae type 4 challenge showed high protective efficacy and also induced a high titer of serum IgG against S. dysenteriae type 4 whole cell lysate (WCL) and LPS. In this study, we report further evaluation of the non-invasive and non-toxic environmental strain DM104 as a vaccine candidate against S. dysenteriae type 4 in mice model. Oral immunization of live DM104 bacterial strain demonstrated better protective immunity in mice model by showing 90% protection in mice against live S. dysenteriae type 4 lethal dose challenge and by inducing effective humoral and mucosal immune responses.
Collapse
Affiliation(s)
- Fatema Moni Chowdhury
- 1Department of Microbiology, University of Dhaka, Dhaka 1000, Bangladesh
- 2Department of Biological Sciences, University of Bergen, Bergen 5020, Norway
| | | | - Nils-Kåre Birkeland
- 2Department of Biological Sciences, University of Bergen, Bergen 5020, Norway
| |
Collapse
|
2
|
Akbari A, Razmjoo M, Foroughi A. Isolation and Identification of Escherichia albertii in Broiler Chickens From Kermanshah. INTERNATIONAL JOURNAL OF ENTERIC PATHOGENS 2021. [DOI: 10.34172/ijep.2021.05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Background: F Escherichia albertii is generally recognized as a human pathogen with a limited number of strains. It has also been identified as a cause of mortality among birds. The clinical significance and prevalence of E. albertii are somewhat unknown. Objectives: The aim of the present study was to isolate and identify E. albertii as a causative agent of respiratory infections in broilers. Materials and Methods: During a three-month period (Winter 2018), 200 samples of the air sacs of 100 chickens with suspected colibacillosis were collected. Routine biochemical tests were performed and suspected isolates of E. albertii were selected for polymerase chain reaction (PCR). Results: A total of 68 suspected samples of E. albertii and Escherichia coli were isolated. Further, E. coli was detected in all the suspected samples using species-specific sequences of E. coli (uidA) and E. albertii (mdh and lysP). Conclusion: Escherichia albertii was not identified as a cause of respiratory infection in broilers.
Collapse
Affiliation(s)
- Adel Akbari
- Department of Pathobiology and Basic Science, Veterinary School, Razi University, Kermanshah, Iran
| | - Mostafa Razmjoo
- Department of Clinical Science, School, Veterinary School, Razi University, Kermanshah, Iran
| | - Azadeh Foroughi
- Department of Pathobiology and Basic Science, Veterinary School, Razi University, Kermanshah, Iran
| |
Collapse
|
3
|
Gomes TAT, Ooka T, Hernandes RT, Yamamoto D, Hayashi T. Escherichia albertii Pathogenesis. EcoSal Plus 2020; 9:10.1128/ecosalplus.ESP-0015-2019. [PMID: 32588811 PMCID: PMC11168576 DOI: 10.1128/ecosalplus.esp-0015-2019] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/11/2020] [Indexed: 12/17/2022]
Abstract
Escherichia albertii is an emerging enteropathogen of humans and many avian species. This bacterium is a close relative of Escherichia coli and has been frequently misidentified as enteropathogenic or enterohemorrhagic E. coli due to their similarity in phenotypic and genetic features, such as various biochemical properties and the possession of a type III secretion system encoded by the locus of enterocyte effacement. This pathogen causes outbreaks of gastroenteritis, and some strains produce Shiga toxin. Although many genetic and phenotypic studies have been published and the genome sequences of more than 200 E. albertii strains are now available, the clinical significance of this species is not yet fully understood. The apparent zoonotic nature of the disease requires a deeper understanding of the transmission routes and mechanisms of E. albertii to develop effective measures to control its transmission and infection. Here, we review the current knowledge of the phylogenic relationship of E. albertii with other Escherichia species and the biochemical and genetic properties of E. albertii, with particular emphasis on the repertoire of virulence factors and the mechanisms of pathogenicity, and we hope this provides a basis for future studies of this important emerging enteropathogen.
Collapse
Affiliation(s)
- Tânia A T Gomes
- Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil
| | - Tadasuke Ooka
- Department of Microbiology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan
| | - Rodrigo T Hernandes
- Universidade Estadual Paulista (UNESP), Instituto de Biociências, Campus de Botucatu, São Paulo, Brazil
| | - Denise Yamamoto
- Universidade Santo Amaro, São Paulo, Brazil
- Departamento de Microbiologia, Imunologia e Parasitologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil
| | - Tetsuya Hayashi
- Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
| |
Collapse
|
4
|
Ooka T, Seto K, Ogura Y, Nakamura K, Iguchi A, Gotoh Y, Honda M, Etoh Y, Ikeda T, Sugitani W, Konno T, Kawano K, Imuta N, Yoshiie K, Hara-Kudo Y, Murakami K, Hayashi T, Nishi J. O-antigen biosynthesis gene clusters of Escherichia albertii: their diversity and similarity to Escherichia coli gene clusters and the development of an O-genotyping method. Microb Genom 2020; 5. [PMID: 31738701 PMCID: PMC6927306 DOI: 10.1099/mgen.0.000314] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Escherichia albertii is a recently recognized human enteropathogen that is closely related to Escherichia coli. In many Gram-negative bacteria, including E. coli, O-antigen variation has long been used for the serotyping of strains. In E. albertii, while eight O-serotypes unique to this species have been identified, some strains have been shown to exhibit genetic or serological similarity to known E. coli/Shigella O-serotypes. However, the diversity of O-serotypes and O-antigen biosynthesis gene clusters (O-AGCs) of E. albertii remains to be systematically investigated. Here, we analysed the O-AGCs of 65 E. albertii strains and identified 40 E. albertii O-genotypes (EAOgs) (named EAOg1–EAOg40). Analyses of the 40 EAOgs revealed that as many as 20 EAOgs exhibited significant genetic and serological similarity to the O-AGCs of known E. coli/Shigella O-serotypes, and provided evidence for the inter-species horizontal gene transfer of O-AGCs between E. albertii and E. coli. Based on the sequence variation in the wzx gene among the 40 EAOgs, we developed a multiplex PCR-based O-genotyping system for E. albertii (EAO-genotyping PCR) and verified its usefulness by genotyping 278 E. albertii strains from various sources. Although 225 (80.9 %) of the 278 strains could be genotyped, 51 were not assigned to any of the 40 EAOgs, indicating that further analyses are required to better understand the diversity of O-AGCs in E. albertii and improve the EAO-genotyping PCR method. A phylogenetic view of E. albertii strains sequenced so far is also presented with the distribution of the 40 EAOgs, which provided multiple examples for the intra-species horizontal transfer of O-AGCs in E. albertii.
Collapse
Affiliation(s)
- Tadasuke Ooka
- Department of Microbiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
| | - Kazuko Seto
- Osaka Institute of Public Health, 1-3-69 Nakamichi, Higasinari-ku, Osaka 537-0025, Japan
| | - Yoshitoshi Ogura
- Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
| | - Keiji Nakamura
- Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
| | - Atsushi Iguchi
- Department of Animal and Grassland Sciences, Faculty of Agriculture, University of Miyazaki, 1-1 Gakuen-kibanadai-nishi, Miyazaki 889-2192, Japan
| | - Yasuhiro Gotoh
- Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
| | - Mikiko Honda
- Fukuoka City Institute of Hygiene and the Environment, 2-1-34 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan
| | - Yoshiki Etoh
- Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka 818-0135, Japan
| | - Tetsuya Ikeda
- Hokkaido Institute of Public Health, Kita-19, Nishi-12, Kita-ku, Sapporo 060-0819, Japan
| | - Wakana Sugitani
- Kumamoto City Environmental Research Institute, 404-1, Ezumachi Tokorojima, Higashi-ku, Kumamoto 862-0946, Japan
| | - Takayuki Konno
- Akita Prefectural Research Center for Public Health and Environment, 6-6 Senshu Kubota-machi, Akita 010-0874, Japan
| | - Kimiko Kawano
- Miyazaki Prefectural Institute for Public Health and Environment, 2-3-2 Gakuen-kibanadai-nishi, Miyazaki 889-2155, Japan
| | - Naoko Imuta
- Department of Microbiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
| | - Kiyotaka Yoshiie
- Department of Microbiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
| | - Yukiko Hara-Kudo
- National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki 210-9501, Japan
| | - Koichi Murakami
- Infectious Disease Surveillance Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-murayama, Tokyo 208-0011, Japan
| | - Tetsuya Hayashi
- Department of Bacteriology, Faculty of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
| | - Junichiro Nishi
- Department of Microbiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan
| |
Collapse
|
5
|
Maheux AF, Brodeur S, Bérubé È, Boudreau DK, Abed JY, Boissinot M, Bissonnette L, Bergeron MG. Method for isolation of both lactose-fermenting and – non-fermenting Escherichia albertii strains from stool samples. J Microbiol Methods 2018; 154:134-140. [DOI: 10.1016/j.mimet.2018.09.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2018] [Revised: 09/17/2018] [Accepted: 09/17/2018] [Indexed: 11/29/2022]
|
6
|
Grillová L, Sedláček I, Páchníková G, Staňková E, Švec P, Holochová P, Micenková L, Bosák J, Slaninová I, Šmajs D. Characterization of four Escherichia albertii isolates collected from animals living in Antarctica and Patagonia. J Vet Med Sci 2017; 80:138-146. [PMID: 29249728 PMCID: PMC5797873 DOI: 10.1292/jvms.17-0492] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023] Open
Abstract
Escherichia albertii is a recently discovered species with a limited number of well characterized strains. The aim of this study was to characterize four of the E. albertii strains, which were among 41 identified Escherichia strains isolated from the feces of living animals on James Ross Island, Antarctica, and Isla Magdalena, Patagonia. Sequencing of 16S rDNA, automated ribotyping, and rep-PCR were used to identify the four E. albertii isolates. Phylogenetic analyses based on multi-locus sequence typing showed these isolates to be genetically most similar to the members of E. albertii phylogroup G3. These isolates encoded several virulence factors including those, which are characteristic of E. albertii (cytolethal distending toxin and intimin) as well as bacteriocin determinants that typically have a very low prevalence in E. coli strains (D, E7). Moreover, E. albertii protein extracts caused cell cycle arrest in human cell line A375, probably because of cytolethal distending toxin activity.
Collapse
Affiliation(s)
- Linda Grillová
- Department of Biology, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic
| | - Ivo Sedláček
- Czech Collection of Microorganisms, Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic
| | - Gabriela Páchníková
- Department of Biology, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic
| | - Eva Staňková
- Czech Collection of Microorganisms, Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic
| | - Pavel Švec
- Czech Collection of Microorganisms, Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic
| | - Pavla Holochová
- Czech Collection of Microorganisms, Department of Experimental Biology, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic
| | - Lenka Micenková
- Research Centre for Toxic Compounds in the Environment, Faculty of Science, Masaryk University, 625 00, Brno, Czech Republic
| | - Juraj Bosák
- Department of Biology, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic
| | - Iva Slaninová
- Department of Biology, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic
| | - David Šmajs
- Department of Biology, Faculty of Medicine, Masaryk University, 625 00, Brno, Czech Republic
| |
Collapse
|
7
|
Arabshahi S, Nayeri Fasaei B, Derakhshandeh A, Novinrooz A. In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate. Bioengineered 2017; 9:170-177. [PMID: 29091543 PMCID: PMC5972921 DOI: 10.1080/21655979.2017.1373535] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
This study aimed to design a novel chimeric protein in silico to serve as a serotype-independent vaccine candidate against Shigella. The chimera contains amino acid residues 240–460 of Shigella invasion plasmid antigen B (IpaB) and the C-terminus of Clostridium perfringens enterotoxin (C-CPE). Amino acid sequences of 537 peptide linkers were obtained from two protein linker databases. 3D structures of IpaB-CPE290–319, IpaB-CPE184–319, IpaB-CPE194–319 and 537 newly designed IpaB-linker-CPE290–319 constructs with varying linker regions were predicted. These predicted 3D structures were merged with the 3D structures of native IpaB240–460, CPE194–319, CPE184–319 and CPE290–319 to select the structure most similar to native IpaB and C-CPE. Several in silico tools were used to determine the suitability of the selected IpaB-C-CPE structure as a vaccine candidate. None of the 537 linkers was capable of preserving the native structure of CPE290–319 within the IpaB-linker-CPE290–319 structure. In silico analysis determined that the IpaB-CPE194–319 3D structure was the most similar to the 3D structure of the respective native CPE domain and that it was a stable chimeric protein exposing multiple B-cell epitopes. IpaB-CPE194–319 was designed for its capability to bind to human intestinal epithelial and M cells and to accumulate on these cells. The predicted B-cell epitopes are likely to be capable of inducing a mucosal antibody response in the human intestine against Shigella IpaB. This study also showed that the higher binding affinities of CPE184–319 and CPE194–319 to claudin molecules than those of CPE290–319 is the result of preserving the 3D structures of CPE184–319 and CPE194–319 when they are linked to the C-termini of other proteins.
Collapse
Affiliation(s)
- Sina Arabshahi
- a Department of Pathobiology , School of Veterinary Medicine, Shiraz University , Shiraz , Iran
| | - Bahar Nayeri Fasaei
- b Department of Microbiology and Immunology, Faculty of Veterinary Medicine , University of Tehran , Tehran , Iran
| | - Abdollah Derakhshandeh
- a Department of Pathobiology , School of Veterinary Medicine, Shiraz University , Shiraz , Iran
| | - Aytak Novinrooz
- a Department of Pathobiology , School of Veterinary Medicine, Shiraz University , Shiraz , Iran
| |
Collapse
|
8
|
Litvinov J, Moen ST, Koh CY, Singh AK. Centrifugal sedimentation immunoassays for multiplexed detection of enteric bacteria in ground water. BIOMICROFLUIDICS 2016; 10:014103. [PMID: 26858815 PMCID: PMC4714988 DOI: 10.1063/1.4939099] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2015] [Accepted: 12/16/2015] [Indexed: 05/19/2023]
Abstract
Waterborne pathogens pose significant threat to the global population and early detection plays an important role both in making drinking water safe, as well as in diagnostics and treatment of water-borne diseases. We present an innovative centrifugal sedimentation immunoassay platform for detection of bacterial pathogens in water. Our approach is based on binding of pathogens to antibody-functionalized capture particles followed by sedimentation of the particles through a density-media in a microfluidic disk. Beads at the distal end of the disk are imaged to quantify the fluorescence and determine the bacterial concentration. Our platform is fast (20 min), can detect as few as ∼10 bacteria with minimal sample preparation, and can detect multiple pathogens simultaneously. The platform was used to detect a panel of enteric bacteria (Escherichia coli, Salmonella typhimurium, Shigella, Listeria, and Campylobacter) spiked in tap and ground water samples.
Collapse
Affiliation(s)
- Julia Litvinov
- Department of Microbiology and Immunology, University of Texas Medical Branch , Galveston, Texas 77555, USA
| | | | - Chung-Yan Koh
- Biotechnology and Bioengineering Department, Sandia National Laboratories , Livermore, California 94550, USA
| | | |
Collapse
|
9
|
Chowdhury FM, Rahman MZ, Khan SI, Ahsan CR, Birkeland NK. An environmental Escherichia albertii strain, DM104, induces protective immunity to Shigella dysenteriae in guinea pig eye model. Curr Microbiol 2014; 68:642-7. [PMID: 24452425 DOI: 10.1007/s00284-014-0522-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2013] [Accepted: 11/28/2013] [Indexed: 10/25/2022]
Abstract
The environmental Escherichia albertii strain DM104, which cross-reacts serologically with Shigella dysenteriae was assessed for pathogenic properties, immunogenicity, and protective efficacy in different animal models to evaluate it as a vaccine candidate against S. dysenteriae, which causes the severe disease, shigellosis. The DM104 isolate was found to be non-invasive and did not produce any entero- or cyto-toxins. The strain also showed negative results in the mouse lethal activity assay. The non-pathogenic DM104 strain gave, however, a high protective efficacy as an ocularly administered vaccine in the guinea pig eye model against S. dysenteriae type 4 challenge. It also induced a high titer of serum IgG against S. dysenteriae type 4 whole cell lysate and lipopolysaccharide. Taken together, all these results indicate a good potential for the use of the DM104 as a live vaccine candidate against shigellosis.
Collapse
|